ATM and breast carcinoma: Using SIFT and PolyPhen tools to predict the possible impact of the amino acid changes on the ATM function, we found 4 of the 6 variants identified only in breast cancer patients could be classified as potentially deleterious mutations that might impair ATM function, suggesting a causality to the disease.